Malignant Pleural Mesothelioma and the Role of Non– Operative Therapies
作者： Kelvin K.W. , Calvin S.H.
DOI: 10.5772/55722
关键词:
摘要: Malignant pleural mesothelioma (MPM) is a primary malignancy of the pleura. The main aetiological agent asbestos. latency period lasts several decades, and in countries where its use was banned 1950’s 1960’s, incidence expected to peak within coming decade. However, many other it continues be mined used. these can continue rise.
intechopen.com
sci-hub.st 参考文章(208)
David C. Rice, Craig W. Stevens, Arlene M. Correa, Ara A. Vaporciyan, Anne Tsao, Kenneth M. Forster, Garrett L. Walsh, Stephen G. Swisher, Wayne L. Hofstetter, Reza J. Mehran, Jack A. Roth, Zhongxing Liao, W. Roy Smythe, Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. The Annals of Thoracic Surgery. ,vol. 84, pp. 1685- 1693 ,(2007) , 10.1016/J.ATHORACSUR.2007.04.076
Muzaffer Metintas, Gunnar Hillerdal, Selma Metintas, Pascal Dumortier, Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors. Archives of Environmental & Occupational Health. ,vol. 65, pp. 86- 93 ,(2010) , 10.1080/19338240903390305
J.C. Halstead, E. Lim, R.M. Venkateswaran, S.C. Charman, M. Goddard, A.J. Ritchie, Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Ejso. ,vol. 31, pp. 314- 320 ,(2005) , 10.1016/J.EJSO.2004.08.014
Claudio Thurneysen, Isabelle Opitz, Stefanie Kurtz, Walter Weder, Rolf A. Stahel, Emanuela Felley-Bosco, Functional inactivation of NF2/merlin in human mesothelioma Lung Cancer. ,vol. 64, pp. 140- 147 ,(2009) , 10.1016/J.LUNGCAN.2008.08.014
Geoffrey Berry, NH De Klerk, Alison Reid, GL Ambrosini, Lin Fritschi, NJ Olsen, E Merler, AW Musk, Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia Occupational and Environmental Medicine. ,vol. 61, ,(2004) , 10.1136/OEM.2003.008128
H. Yang, M. Bocchetta, B. Kroczynska, A. G. Elmishad, Y. Chen, Z. Liu, C. Bubici, B. T. Mossman, H. I. Pass, J. R. Testa, G. Franzoso, M. Carbone, TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 10397- 10402 ,(2006) , 10.1073/PNAS.0604008103
Joseph LaDou, Barry Castleman, Arthur Frank, Michael Gochfeld, Morris Greenberg, James Huff, Tushar Kant Joshi, Philip J. Landrigan, Richard Lemen, Jonny Myers, Morando Soffritti, Colin L. Soskolne, Ken Takahashi, Daniel Teitelbaum, Benedetto Terracini, Andrew Watterson, The case for a global ban on asbestos. Environmental Health Perspectives. ,vol. 118, pp. 897- 901 ,(2010) , 10.1289/EHP.1002285
Marie-Anne Froment, Éric Fréchette, Anne Dagnault, Prophylactic irradiation of intervention sites in malignant pleural mesothelioma Radiotherapy and Oncology. ,vol. 101, pp. 307- 310 ,(2011) , 10.1016/J.RADONC.2011.08.038
Johannes Hierholzer, Liangping Luo, Roland C. Bittner, Christian Stroszczynski, Ralf-Ju¨rgen Schro¨der, Nicolas Schoenfeld, Peter Dorow, Robert Loddenkemper, Anne Grassot, MRI and CT in the Differential Diagnosis of Pleural Disease Chest. ,vol. 118, pp. 604- 609 ,(2000) , 10.1378/CHEST.118.3.604
Martin F Muers, Richard J Stephens, Patricia Fisher, Liz Darlison, Christopher MB Higgs, Erica Lowry, Andrew G Nicholson, Mary O'Brien, Michael Peake, Robin Rudd, Michael Snee, Jeremy Steele, David J Girling, Matthew Nankivell, Cheryl Pugh, Mahesh KB Parmar, Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial The Lancet. ,vol. 371, pp. 1685- 1694 ,(2008) , 10.1016/S0140-6736(08)60727-8